GALNT2 antibody (AA 442-571) (Fluoro550)
Quick Overview for GALNT2 antibody (AA 442-571) (Fluoro550) (ABIN8052711)
Target
See all GALNT2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 442-571
-
Purpose
- Anti-GALNT2 Antibody Fluoro550 Conjugated
-
Predicted Reactivity
- Human GALNT2 shares 96.9% amino acid (aa) sequence identity with mouse GALNT2.
-
Purification
- Immunogen affinity purified.
-
Immunogen
- E.coli-derived human GALNT2 recombinant protein (Position: H442-Q571). Human GALNT2 shares 96.9% amino acid (aa) sequence identity with mouse GALNT2.
-
Isotype
- IgG
-
-
-
-
Application Notes
- Flow Cytometry, Optimal dilutions should be determined by end users.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
-
Expiry Date
- 12 months
-
-
- GALNT2 (UDP-N-Acetyl-alpha-D-Galactosamine:polypeptide N-Acetylgalactosaminyltransferase 2 (GalNAc-T2) (GALNT2))
-
Alternative Name
- GALNT2
-
Background
-
Background: Polypeptide N-acetylgalactosaminyltransferase 2 is an enzyme that in humans is encoded by the GALNT2 gene. This gene encodes a member of the glycosyltransferase 2 protein family. Members of this family initiate mucin-type O-glycoslation of peptides in the Golgi apparatus. The encoded protein may be involved in O-linked glycosylation of the immunoglobulin A1 hinge region. This gene may influence triglyceride levels, and may be involved Type 2 diabetes, as well as several types of cancer. Alternative splicing results in multiple transcript variants.
Gene Full Name: polypeptide N-acetylgalactosaminyltransferase 2
-
Gene ID
- 2590
-
UniProt
- Q10471
-
Pathways
- Production of Molecular Mediator of Immune Response
Target
-